Genetically modified food gave rise to several controversies since it came into being. The clash of international GMF legislation is rooted in the divergence of the EU and the US legislation, which leads to the divergence of the WTO and Cartagena Protocol on Biosafety and indirectly influences the legislative choice of developing countries. Like other developing countries, China also faces lots of challenges including lag in genetically modified organism technology, disadvantage caused by invisible private standard, technical control of GMO companies in developed countries and low level of involvement of the public. In recent years, China adopts its own policy on GMO by developing GM technology cautiously. The legislative situation in China fall far behind domestic research and commercial production necessity. China has revised several existing legislations. Although there is far from perfect, it makes great progress. In the future, China is expected to be more active, positive and open towards GMO.

I. Introduction
 II. Conflict between the EU and the US onGMF Safety Legis lation
  A. Different Legislative Principle
  B. Labelling System Difference
  C. Regulatory Models Difference
 III. Conflict between the WTO and CPB
  A. Difference of Aim and Scope
  B. Difference of Core Principle
 IV. Conflicts between Developed andDevelopi ng Countries
 V. Accomp lis hments and Limi tations ofInternational Reconciliation onGMF Safety Legis lation
  A. Accomplishments: Unified Standards by FAO,WHO, CAC and OECD
  B. Shortcomings
 VI. Latest Developm ent and Dilemm as ofChinese Genetically Modified Food
  A. Contemporary Chinese GMF Commercial Practice
  B. Chinese Governmental Attitude and Policy on GMF
  C. Chinese GMF Legislation: General View and Latest Reform
  D. China’s Dilemma and Choice
 VII. Conclusi on
 References

• Yayun Chen(Associate Professor at Henan University)